SHALINI MAKAWITA to Protein Kinase Inhibitors
This is a "connection" page, showing publications SHALINI MAKAWITA has written about Protein Kinase Inhibitors.
Connection Strength
0.125
-
Infigratinib in patients with advanced cholangiocarcinoma with FGFR2 gene fusions/translocations: the PROOF 301 trial. Future Oncol. 2020 Oct; 16(30):2375-2384.
Score: 0.125
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.